A Single Dose of the Selective Serotonin Reuptake Inhibitor Citalopram Exacerbates Anxiety in Humans: A Fear-Potentiated Startle Study
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Serotonin reuptake inhibitors may increase symptoms of anxiety immediately following treatment initiation. The present study examined whether acute citalopram increased fear-potentiated startle to predictable and/or unpredictable shocks in healthy subjects. Eighteen healthy subjects each received two treatments, placebo and 20 mg citalopram in a crossover design. Participants were exposed to three conditions including one in which predictable aversive shocks were signaled by a cue, a second in which unpredictable shocks were anticipated, and a third in which no shocks were administered. Changes in aversive states were investigated using acoustic startle stimuli. Citalopram did not affect baseline startle. However, the phasic startle potentiation to the threat cue in the predictable condition was robustly increased by acute citalopram. The sustained startle potentiation in the unpredictable conditions was also increased by citalopram, but only when the drug was given during the first session. These results indicate that a single dose of citalopram is not anxiogenic in itself, but can exacerbate the expression of fear and anxiety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although acute citalopram increased both fear and anxiety to predictable and unpredictable shock, respectively (Grillon et al, 2007)”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Grillon et al, 2007
In the citing paper
“Seven days' treatment with citalopram, but not reboxetine, reduced the emotion-potentiated startle,25 and in line with clinical experience and effects on fearful face recognition, a single dose of citalopram potentiates this startle response.59”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [59]
In the citing paper
“Following both single doses of citalopram (reflecting possible early anxiogenic responses)28,59 and acute tryptophan depletion75 negative changes in emotional processing can be measured in healthy volunteer models”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [59]
Citations
Cites
(1970) · Cited by 24,983
Conscious and unconscious emotional learning in the human amygdala
Morris, J. S., Öhman, A., & Dolan, R. J. (1998) · Nature · doi:10.1038/30976 · Cited by 1,665 · cited 1×
“This would be consistent with findings that the amygdala can be activated without alteration in conscious mood (Morris et al, 1998).”
ResultClassical fear-conditioning in the anxiety disorders: a meta-analysis
Lissek, S., Powers, A. S., McClure, E. B., Phelps, E. A., Woldehawariat, G., Grillon, C., & Pine, D. S. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.10.007 · Cited by 1,034 · cited 1×
“…Group All rights reserved 0893-133X/07 $30.00 www.neuropsychopharmacology.org dure was implemented instead of a conditioning procedure given that abnormal responses to verbal threat more consistently characterize clinical anxiety states, relative to conditioning procedure (Lissek et al, 2005a, b).”
MethodSelf-citationRole of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838 · cited 8×
“The amygdala is also involved in the initiation of sustained aversive responses (Walker et al, 2003).”
BackgroundMethodInfluentialGrillon, C., & Baas, J. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00202-5 · Cited by 563 · cited 1×
“Moreover, this design focuses on modulatory influences on expressions of aversive responses rather than learning and memory processes inherently associated with associative learning procedures (Grillon and Baas, 2003).”
BackgroundSelf-citationAutoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537 · cited 4×
“The initially anxiogenic-like effects may result from an acute increased availability of serotonin on inhibitory 5HT1A autoreceptors, leading to a reduced firing of ascending serotonin raphe neurons, until adaptive changes ensue following chronic treatment (Piñeyro and Blier, 1999).”
BackgroundInfluentialFear‐Potentiated Startle in Humans: Effects of Anticipatory Anxiety on the Acoustic Blink Reflex
Grillon, C., AMELI, R., Woods, S. W., Merikangas, K., & Davis, M. (1991) · Psychophysiology · doi:10.1111/j.1469-8986.1991.tb01999.x · Cited by 462 · cited 1×
“Prior studies with this paradigm show that threat cues are very easy to discriminate from safe cues (Grillon et al, 1991).”
BackgroundSelf-citationAcute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers
Harmer, C. J., Bhagwagar, Z., Perrett, D. I., Völlm, B. A., Cowen, P. J., & Goodwin, G. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300004 · Cited by 420 · cited 7×
“This effect is consistent with clinical reports of symptom exacerbation following treatment initiation (Gorman et al, 1987; Ramos et al, 1993) and with evidence of facilitation of processing threat cues in experimental models following acute SSRIs (Burghardt et al, 2004; Harmer et al, 2003b).”
BackgroundResultInfluentialAnxious Responses to Predictable and Unpredictable Aversive Events.
Grillon, C., Baas, J. P., Lissek, S., Smith, K., & Milstein, J. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.5.916 · Cited by 349 · cited 2×
“…two threat responses: a phasic fear-potentiated startle response associated with a cue and a more sustained startle potentiation generated by less explicit threat (Grillon et al, 2005, 2004) by administering predictable (ie signaled by a cue) or unpredictable (ie unsignaled) shocks, respectively.”
BackgroundResultSelf-citationSánchez, C., & Meier, E. (1997) · Psychopharmacology · doi:10.1007/s002130050181 · Cited by 255 · cited 1×
“In animals, acute serotonin can increase (Bagdy et al, 2001; Griebel et al, 1994) or decrease (Inoue et al, 1996, 2004; Sanchez and Meier, 1997) anxiety-like responses, depending on the model used.”
BackgroundBagdy, G., Graf, M., Anheuer, Z. E., Modos, E. A., & Kantor, S. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002632 · Cited by 247 · cited 2×
“In animals, acute serotonin can increase (Bagdy et al, 2001; Griebel et al, 1994) or decrease (Inoue et al, 1996, 2004; Sanchez and Meier, 1997) anxiety-like responses, depending on the model used.”
BackgroundBurghardt, N. S., Sullivan, G. M., McEwen, B. S., Gorman, J. M., & LeDoux, J. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.029 · Cited by 246 · cited 5×
“This effect is consistent with clinical reports of symptom exacerbation following treatment initiation (Gorman et al, 1987; Ramos et al, 1993) and with evidence of facilitation of processing threat cues in experimental models following acute SSRIs (Burghardt et al, 2004; Harmer et al, 2003b).”
BackgroundResultInfluentialFunayama, E. S., Grillon, C., Davis, M., & Phelps, E. A. (2001) · Journal of Cognitive Neuroscience · doi:10.1162/08989290152541395 · Cited by 225 · cited 1×
“The amygdala, which receives serotoninergic innervations from the median raphe nucleus (Vertes et al, 1999), is involved in fear to verbal threat (Phelps et al, 1998; Funayama et al, 2001).”
BackgroundSelf-citationDual role of 5-HT in defense and anxiety
Graeff, F. G., Viana, M. B., & Mora, P. O. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00059-0 · Cited by 195 · cited 1×
“This would be consistent with the hypothesis that serotonin has effects on multiple brain structures that mediate anxiety via multiple pathways and receptors (Graeff et al, 1997).”
ResultAn open trial of fluoxetine in the treatment of panic attacks.
Gorman, J. M., Liebowitz, M. R., Fyer, A. J., Goetz, D. M., Campeas, R. B., Fyer, M. R., Davies, S. O., & Klein, D. F. (1987) · PubMed · Cited by 192
An Open Trial of Fluoxetine in the Treatment of Panic Attacks
GORMAN, J. M., LIEBOWITZ, M. R., FYER, A. J., GOETZ, D., CAMPEAS, R. B., FYER, M. R., DAVIES, S. O., & KLEIN, D. F. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198710000-00007 · Cited by 175 · cited 3×
“This exacerbation of symptoms can be an obstacle to treatment continuation; dropout rates as high as 50% have been reported (Gorman et al, 1987).”
BackgroundResultA neuroendocrine mechanism for sustaining fear
Schulkin, J., Morgan, M. A., & Rosen, J. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.09.009 · Cited by 166 · cited 5×
“More specifically, fear-potentiated startle to a discrete cue is mediated by the amygdala, whereas the more sustained startle potentiation is mediated by both the amygdala and the bed nucleus of the stria terminalis (BNST) (Walker et al, 2003).”
BackgroundInfluentialTryptophan depletion decreases the recognition of fear in female volunteers
Harmer, C. J., Rogers, R. D., Tunbridge, E., Cowen, P. J., & Goodwin, G. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1401-6 · Cited by 163 · cited 7×
“This effect is consistent with clinical reports of symptom exacerbation following treatment initiation (Gorman et al, 1987; Ramos et al, 1993) and with evidence of facilitation of processing threat cues in experimental models following acute SSRIs (Burghardt et al, 2004; Harmer et al, 2003b).”
BackgroundResultInfluentialGrillon, C., Baas, J. M. P., Pine, D. S., Lissek, S., Lawley, M., Ellis, V., & Levine, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.027 · Cited by 157 · cited 2×
“…two threat responses: a phasic fear-potentiated startle response associated with a cue and a more sustained startle potentiation generated by less explicit threat (Grillon et al, 2005, 2004) by administering predictable (ie signaled by a cue) or unpredictable (ie unsignaled) shocks, respectively.”
BackgroundResultSelf-citationGriebel, G., Moreau, J., Jenck, F., Misslin, R., & Martin, J. R. (1994) · Psychopharmacology · doi:10.1007/bf02245224 · Cited by 138 · cited 1×
“In animals, acute serotonin can increase (Bagdy et al, 2001; Griebel et al, 1994) or decrease (Inoue et al, 1996, 2004; Sanchez and Meier, 1997) anxiety-like responses, depending on the model used.”
BackgroundEffects of ritanserin on aversive classical conditioning in humans
Hensman, R., Guimarães, F. S., Wang, M., & Deakin, J. F. W. (1991) · Psychopharmacology · doi:10.1007/bf02244182 · Cited by 112 · cited 1×
“In addition, acute administration of serotonin-receptor blockers resanterin decreases conditioned responses to aversive loud noises (Hensman et al, 1991; Silva et al, 2001).”
BackgroundAcute administration of citalopram facilitates memory consolidation in healthy volunteers
Harmer, C. J., Bhagwagar, Z., Cowen, P. J., & Goodwin, G. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1151-x · Cited by 112 · cited 1×
“This effect was attributed (Burghardt et al, 2004) to better learning, based on the finding that acute citalopram facilitates recall and recognition of verbal material in humans (Harmer et al, 2002).”
BackgroundCitalopram: a comprehensive review
Pollock, B. G. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.4.681 · Cited by 109 · cited 1×
“The anxiogenic effects of acute citalopram are likely to be mediated by action on the reuptake of serotonin because citalopram has minimal effect on dopamine and noradrenalin transporters and has little affinity for a variety of neurotransmitter receptors (Noble and Benfield, 1997; Pollock, 2001).”
BackgroundSelective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala
Inoue, T., Li, X. B., Abekawa, T., Kitaichi, Y., Izumi, T., Nakagawa, S., & Koyama, T. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.061 · Cited by 108 · cited 2×
“Citalopram impairs context conditioning (Inoue et al, 1996, 2004) but fluvoxamine does not affect light-enhanced startle (de Jong et al, 2002).”
BackgroundKemp, A. H., Gray, M. A., Silberstein, R. B., Armstrong, S. M., & Nathan, P. J. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.03.022 · Cited by 107 · cited 2×
“Similarly, acute citalopram affects behavioral, cortical, and physiological responses to emotional stimuli in the absence of conscious changes in subjective feelings (Kemp et al, 2004).”
BackgroundSerotonergic activation reduces defensive freezing in the conditioned fear paradigm
Inoue, T. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02084-5 · Cited by 106 · cited 2×
“Citalopram impairs context conditioning (Inoue et al, 1996, 2004) but fluvoxamine does not affect light-enhanced startle (de Jong et al, 2002).”
BackgroundEffects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression
de Oliveira, C. L., Sales, A. J., Bel, E. A. D., Silveira, M. C. L., & Guimarães, F. S. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00566-4 · Cited by 105 · cited 1×
“Furthermore, acute treatment with SSRIs increases c-fos immunoreactivity in the amygdala (Lino-de-Oliveira et al, 2001).”
BackgroundHuntley, G. W., & Benson, D. L. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990517)407:4<453::aid-cne1>3.0.co;2-4 · Cited by 91
Noble, S., & Benfield, P. (1997) · CNS Drugs · doi:10.2165/00023210-199708050-00009 · Cited by 86 · cited 1×
“The anxiogenic effects of acute citalopram are likely to be mediated by action on the reuptake of serotonin because citalopram has minimal effect on dopamine and noradrenalin transporters and has little affinity for a variety of neurotransmitter receptors (Noble and Benfield, 1997; Pollock, 2001).”
BackgroundLow-dose citalopram as a 5-HT neuroendocrine probe
Attenburrow, M.-J., Mitter, P. R., Whale, R., Terao, T., & Cowen, P. J. (2001) · Psychopharmacology · doi:10.1007/s002130100729 · Cited by 80 · cited 1×
“Acute citalopram can increase cortisol levels (Attenburrow et al, 2001).”
Effects of threat of shock, shock electrode placement and darkness on startle
Grillon, C., & Ameli, R. (1998) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(97)00072-x · Cited by 70 · cited 1×
“Placing the shock electrodes and starting a threat experiment can potentiate startle (Grillon and Ameli, 1998).”
BackgroundSelf-citationde Jongh, R., Groenink, L., van der Gugten, J., & Olivier, B. (2002) · Psychopharmacology · doi:10.1007/s002130100914 · Cited by 70 · cited 1×
“Citalopram impairs context conditioning (Inoue et al, 1996, 2004) but fluvoxamine does not affect light-enhanced startle (de Jong et al, 2002).”
BackgroundPhelix, C. F., Liposits, Z., & Paull, W. K. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90217-l · Cited by 48 · cited 1×
“…possible that serotonin modulation in the BNST mediates the anxiogenic effects of citalopram on responses to unpredictable shocks given that this structure, which modulates response to unpredictable stressors, also receives serotoninergic innervations from the raphe nucleus (Phelix et al, 1992).”
BackgroundOpposite effects of nefazodone in two human models of anxiety
Silva, M., Hetem, L. A. B., Guimarães, F. S., & Graeff, F. G. (2001) · Psychopharmacology · doi:10.1007/s002130100752 · Cited by 40 · cited 1×
“In addition, acute administration of serotonin-receptor blockers resanterin decreases conditioned responses to aversive loud noises (Hensman et al, 1991; Silva et al, 2001).”
BackgroundClomipramine and initial worsening in panic disorder: beyond the 'jitteriness syndrome'
Ramos, R. T., Gentil, V., & Gorenstein, C. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700305 · Cited by 39 · cited 2×
“Shortly after treatment initiation, a substantial number of patients report exacerbation characterized by ‘jitteriness’, anxiety, nervousness, restlessness, agitation, irritability, accompanied by sleep and gastrointestinal disturbance (Gorman et al, 1987; Ramos et al, 1993).”
BackgroundResult
Research works printed but not linked: 3
- First MB, Spitzer RI, Williams JBW, Gibbon M (1995). Structured Clinical Interview for DSM-V (SCID). American Psychiatric Association: Washington, DC.
- Phelps EA, O'Connor KJ, Gatenby JC, Anderson AK, Grillon C, Davis M et al (1998). Activation of the human amygdala by a cognitive representation of fear: an FMRI study. Soc Neurosci Abstr 24: 1524.
- Vertes RP, Fortin WJ, Crane AM (1999). Projections of the median raphe nucleus in the rat. J Comp Neurol 407: 555–582. · DOI · Paper page
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Self-citationHarmer, C. J., Goodwin, G. M., & Cowen, P. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051193 · Cited by 542
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535
Schmitz, A., & Grillon, C. (2012) · Nature Protocols · doi:10.1038/nprot.2012.001 · Cited by 383
Self-citationGrillon, C., Lissek, S., Rabin, S., McDowell, D., Dvir, S., & Pine, D. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07101581 · Cited by 300
“Both the large fear-potentiated startle response to the threat cue (15, 20, 21) and the similar degree of potentiation across groups replicate previous findings (13, 14).”
MethodResultSelf-citation
Metadata
- Authors
- Grillon, C., Levenson, J., & Pine, D. S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Grillon, Christian
- Venue
- Neuropsychopharmacology
- Published
- 2006-09-13
- Volume
- 32
- Issue
- 1
- Pages
- 225-231
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2030071660
- Cited by
- 162
- References
- 36
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 15 · 2014: 10 · 2013: 11 · 2012: 11
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- citalopram, selective serotonin reuptake inhibitors, anxiogenic effects, fear potentiation, acoustic startle response, anxiety, acute drug effects
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Anxiety, Double-Blind Method, Electroshock, Fear, Female, Humans, Male, Predictive Value of Tests, Reflex, Startle, Citalopram, Selective Serotonin Reuptake Inhibitors, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.